CAR T-cells as Third-line and Beyond Therapy for FL
Bijal Shah, MD, discusses recent data on CAR T-cell therapy as third-line and beyond treatment for FL.
Source: onclive.com
Elara Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Elara Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Elara Study Today - Breaking & Trending Today
Tisagenlecleucel Yields Durable Responses in R/R Follicular Lymphoma
Patients with relapsed/refractory follicular lymphoma experienced durable responses when treated with tisagenlecleucel (Kymriah) in the phase 2 ELARA study (NCT03568461), according to data presented at the 2023 ASH Annual Meeting.
Source: onclive.com